David S. Smith appointed to the Board of Directors of Predictive Oncology
EAGAN, Minn., Oct. 25, 2022 (GLOBE NEWSWIRE) — Predictive Oncology is pleased to announce the appointment of David S. Smith, JD, to the company’s Board of Directors. Mr. Smith is a life sciences and corporate attorney, veteran biotech industry executive and leading authority on the legal issues surrounding the therapeutic use of human tissue and cells. He has extensive transactional experience, venture financings and regulatory matters for life sciences